Results 231 to 240 of about 3,567,577 (243)

Proof of concept of a new plasma complement Factor H from waste plasma fraction. [PDF]

open access: yesFront Immunol
Mori F   +14 more
europepmc   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

Mapping the interaction sites of human and avian influenza A viruses and complement factor H. [PDF]

open access: yesFront Immunol
Rabeeah I   +10 more
europepmc   +1 more source

Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial. [PDF]

open access: yesNat Commun
Clarke JM   +17 more
europepmc   +1 more source

SARS-CoV-2 hijacks host CD55, CD59 and factor H to impair antibody-dependent complement-mediated lysis. [PDF]

open access: yesEmerg Microbes Infect
Gebetsberger L   +10 more
europepmc   +1 more source

Association of complement factor H gene polymorphisms with age-related macular egeneration susceptibility.

open access: green, 2015
Xiaofeng Hao   +7 more
openalex   +1 more source

Complement factor H Val62Ile variant and risk of age-related macular degeneration: a meta-analysis.

open access: green, 2013
Dongqing Yuan   +6 more
openalex   +1 more source

Home - About - Disclaimer - Privacy